Table of Contents Author Guidelines Submit a Manuscript
Pain Research and Management
Volume 2017 (2017), Article ID 7962135, 12 pages
Clinical Study

Clinical Evaluation of a Novel Technology for Oral Patient-Controlled Analgesia, the PCoA® Acute Device, for Hospitalized Patients with Postoperative Pain, in Pilot Feasibility Study

1Department of Anesthesia, Intensive Medicine, Pain Medicine/Palliative Medicine, Center for Pain Medicine, CURA Hospital GFO, Bad Honnef, Germany
2DosentRx Ltd., 2 Hahar St., Har Tuv Industrial Zone A, 9980101 Har Tuv, Israel
3Department of Anesthesia, Interdisciplinary Intensive Care, Emergency Medicine and Pain Medicine, EvK-Protestant Hospital Herne, Herne, Germany

Correspondence should be addressed to Ronit Shtrichman

Received 10 May 2017; Revised 5 July 2017; Accepted 10 August 2017; Published 28 September 2017

Academic Editor: Shinya Kasai

Copyright © 2017 Stefan Wirz et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Background. Acute postoperative pain delays recovery and increases morbidity and mortality. Traditional administration of postoperative analgesics by nurses is often inefficient. The present study evaluated the safety, efficacy, and usability of a novel, patient-controlled analgesic dispenser, the PCoA Acute. Methods. A controlled pilot study was conducted at three medical centers. Patients scheduled for elective surgery were enrolled into two groups, both taking oral analgesics: a control group (), opioids dispensed by nurses, and a test group (), opioids dispensed via the PCoA Acute. Pill intake data were recorded. Pain ratings at rest and during movement were surveyed. Results. No severe adverse events were recorded. Average pill intake time was reduced from 8 : 58 minutes in the control group to 1 : 17 minutes in the test group ( value < 0.05). The test group took 67% more pills than the control group, indicating enhanced compliance. Pain scores were significantly lower for patients in the test group ( value < 0.05). Over 90% of PCoA Acute users were satisfied with its use. Conclusions. The study confirmed that PCoA Acute is safe and effective. It is well accepted by patients and medical staff. Its use can optimize pain medication administration.